Locations:
SearchAdvertisement
Findings strengthen evidence for risk-reducing procedures
Pregnancy did not appear to increase the risk of recurrence in patients or complications in their children
Key research findings to watch
San Antonio Breast Cancer Symposium presentations underscore safety of assisted reproductive technology and pregnancy in women during and after breast cancer treatment
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Analysis suggests association between prior PARP inhibition and subsequent decreased progression-free survival in platinum-sensitive ovarian cancer
Other reproductive and hormonal factors found protective
Will hormone replacement therapy increase breast cancer risk?
Developing and delivering the care most needed by patients, now
Immunotherapy, PARP inhibitors and a targeted therapy
Advertisement
Advertisement